PharmAkea Therapeutics Receives $45,000,000 Series A Funding Round

  • Feed Type
  • Date
    10/8/2013
  • Company Name
    PharmAkea Therapeutics
  • Mailing Address
    12780 El Camino Real San Diego, CA 92130
  • Company Description
    PharmAkea is a biopharmaceutical company based in San Diego, CA. The company is developing high-quality, small molecule drug candidates against protein targets involved in fibroproliferative diseases.
  • Website
    http://www.pharmakea.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $45,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Bay City Capital
  • Venture Investor
    Celgene